Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10486251 | Value in Health | 2015 | 8 Pages |
Abstract
Although high-dose HD has the potential to offer improved clinical and quality-of-life outcomes over conventional ICHD, under the current UK Payment-by Results reimbursement scheme, it would be considered cost-effective from a UK payer perspective only if conducted at home.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Frank Xiaoqing PhD, Catrin MSc, Murat MBA, Lydia MSc, Bruce MD,